Company intelligence / Profile preview

Wire Sciences

Suzhou, Jiangsu, China

Ownership: Private
Development stage: Other

Overview

Wire Sciences is developing innovative interventional surgical robots designed to improve the efficiency, accuracy, and stability of vascular intervention procedures. Their technology has been recognized by leading experts in China and aims to provide comprehensive solutions for clinicians performing coronary, intracranial, and peripheral vascular interventions. The company recently received a strategic investment from Zylox-Tonbridge to accelerate development and commercialization efforts

Therapeutic areas: Cardiovascular
Modalities: DeviceRobotic surgical system
Industry: Surgical Medical Devices

Partnerships

Zylox-Tonbridge – strategic investment and exclusive distribution rights in select regions for the robotic platform developed by Wire Sciences

Beyond the preview

Go deeper on Wire Sciences.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Wire Sciences.

Explore the full profile